Cargando…
Immunological aspects of the efficiency of protectotype vaccination strategy against chicken infectious bronchitis
BACKGROUND: One of the most commonly applied protectotype vaccination protocol against infectious bronchitis (IB) in broiler chickens in the EU is simultaneous or alternate use of Ma5 and 4/91 vaccine strains. After IB vaccination and infection, systemic and upper respiratory tract (URT), humoral an...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5299672/ https://www.ncbi.nlm.nih.gov/pubmed/28178957 http://dx.doi.org/10.1186/s12917-017-0963-1 |
_version_ | 1782506070891036672 |
---|---|
author | Smialek, Marcin Tykalowski, Bartlomiej Dziewulska, Daria Stenzel, Tomasz Koncicki, Andrzej |
author_facet | Smialek, Marcin Tykalowski, Bartlomiej Dziewulska, Daria Stenzel, Tomasz Koncicki, Andrzej |
author_sort | Smialek, Marcin |
collection | PubMed |
description | BACKGROUND: One of the most commonly applied protectotype vaccination protocol against infectious bronchitis (IB) in broiler chickens in the EU is simultaneous or alternate use of Ma5 and 4/91 vaccine strains. After IB vaccination and infection, systemic and upper respiratory tract (URT), humoral and cell-mediated immunity (CMI), are stimulated. The level of this stimulation correlates with the level of protection against IB. RESULTS: We’ve investigated the development of URT and systemic, cell-mediated and humoral immunity in commercial broiler chickens vaccinated with Ma5 and/or 4/91 strains at hatch day. We’ve demonstrated that the group vaccinated with Ma5 and 4/91 strain simultaneously developed the most desirable immunity which reflects the level of CD8(+) T cells stimulation in spleen and Harderian gland, as well as the level of IgA and IgY in URT washings and serum and their cross-reactivity with 7 IBV strains. CONCLUSIONS: Although we did not demonstrate directly why Ma5 + 4/91 protocol is so efficient it seems that it combines the benefits of monovalent vaccination with either Ma5 or 4/91 and while Ma5 seems to stimulate CMI more efficiently, the 4/91 strain generates a wider spectrum of immune system cross-reactivity and higher URT IgA production. |
format | Online Article Text |
id | pubmed-5299672 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-52996722017-02-13 Immunological aspects of the efficiency of protectotype vaccination strategy against chicken infectious bronchitis Smialek, Marcin Tykalowski, Bartlomiej Dziewulska, Daria Stenzel, Tomasz Koncicki, Andrzej BMC Vet Res Research Article BACKGROUND: One of the most commonly applied protectotype vaccination protocol against infectious bronchitis (IB) in broiler chickens in the EU is simultaneous or alternate use of Ma5 and 4/91 vaccine strains. After IB vaccination and infection, systemic and upper respiratory tract (URT), humoral and cell-mediated immunity (CMI), are stimulated. The level of this stimulation correlates with the level of protection against IB. RESULTS: We’ve investigated the development of URT and systemic, cell-mediated and humoral immunity in commercial broiler chickens vaccinated with Ma5 and/or 4/91 strains at hatch day. We’ve demonstrated that the group vaccinated with Ma5 and 4/91 strain simultaneously developed the most desirable immunity which reflects the level of CD8(+) T cells stimulation in spleen and Harderian gland, as well as the level of IgA and IgY in URT washings and serum and their cross-reactivity with 7 IBV strains. CONCLUSIONS: Although we did not demonstrate directly why Ma5 + 4/91 protocol is so efficient it seems that it combines the benefits of monovalent vaccination with either Ma5 or 4/91 and while Ma5 seems to stimulate CMI more efficiently, the 4/91 strain generates a wider spectrum of immune system cross-reactivity and higher URT IgA production. BioMed Central 2017-02-08 /pmc/articles/PMC5299672/ /pubmed/28178957 http://dx.doi.org/10.1186/s12917-017-0963-1 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Smialek, Marcin Tykalowski, Bartlomiej Dziewulska, Daria Stenzel, Tomasz Koncicki, Andrzej Immunological aspects of the efficiency of protectotype vaccination strategy against chicken infectious bronchitis |
title | Immunological aspects of the efficiency of protectotype vaccination strategy against chicken infectious bronchitis |
title_full | Immunological aspects of the efficiency of protectotype vaccination strategy against chicken infectious bronchitis |
title_fullStr | Immunological aspects of the efficiency of protectotype vaccination strategy against chicken infectious bronchitis |
title_full_unstemmed | Immunological aspects of the efficiency of protectotype vaccination strategy against chicken infectious bronchitis |
title_short | Immunological aspects of the efficiency of protectotype vaccination strategy against chicken infectious bronchitis |
title_sort | immunological aspects of the efficiency of protectotype vaccination strategy against chicken infectious bronchitis |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5299672/ https://www.ncbi.nlm.nih.gov/pubmed/28178957 http://dx.doi.org/10.1186/s12917-017-0963-1 |
work_keys_str_mv | AT smialekmarcin immunologicalaspectsoftheefficiencyofprotectotypevaccinationstrategyagainstchickeninfectiousbronchitis AT tykalowskibartlomiej immunologicalaspectsoftheefficiencyofprotectotypevaccinationstrategyagainstchickeninfectiousbronchitis AT dziewulskadaria immunologicalaspectsoftheefficiencyofprotectotypevaccinationstrategyagainstchickeninfectiousbronchitis AT stenzeltomasz immunologicalaspectsoftheefficiencyofprotectotypevaccinationstrategyagainstchickeninfectiousbronchitis AT koncickiandrzej immunologicalaspectsoftheefficiencyofprotectotypevaccinationstrategyagainstchickeninfectiousbronchitis |